Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Flavia Hoyte

Concepts (127)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
32
2026
1800
3.930
Why?
Anti-Asthmatic Agents
19
2026
263
3.530
Why?
Biological Products
11
2025
257
2.730
Why?
Rhinitis, Allergic
4
2024
41
1.190
Why?
Sinusitis
4
2024
220
1.160
Why?
Nasal Polyps
3
2024
59
1.140
Why?
Hypersensitivity
3
2024
253
1.070
Why?
Rhinitis
3
2024
159
1.050
Why?
Remission Induction
3
2026
308
0.900
Why?
Antibodies, Monoclonal, Humanized
7
2025
992
0.900
Why?
Adrenal Cortex Hormones
9
2025
483
0.840
Why?
Bronchodilator Agents
3
2023
186
0.760
Why?
Curcumin
1
2022
29
0.720
Why?
Urticaria
1
2022
38
0.720
Why?
Pancreatitis
2
2012
146
0.660
Why?
Respiratory Tract Diseases
2
2012
178
0.640
Why?
Desensitization, Immunologic
2
2018
91
0.630
Why?
Allergens
2
2024
390
0.610
Why?
Aspirin
3
2018
404
0.590
Why?
Sublingual Immunotherapy
1
2018
4
0.560
Why?
Exhalation
1
2018
28
0.560
Why?
Severity of Illness Index
9
2026
2910
0.490
Why?
Nebulizers and Vaporizers
3
2025
63
0.450
Why?
Immunoglobulin E
4
2025
315
0.450
Why?
Adrenergic beta-2 Receptor Agonists
2
2025
26
0.440
Why?
Nitric Oxide
2
2024
883
0.430
Why?
Anti-Allergic Agents
1
2014
41
0.400
Why?
Histamine
3
2022
52
0.400
Why?
Skin Tests
2
2024
94
0.380
Why?
Voice Disorders
1
2012
21
0.380
Why?
Vocal Cords
1
2012
27
0.370
Why?
Eosinophils
6
2025
319
0.370
Why?
Administration, Inhalation
5
2025
567
0.360
Why?
Humans
41
2026
145625
0.350
Why?
Double-Blind Method
4
2024
2064
0.340
Why?
Muscarinic Antagonists
2
2025
30
0.340
Why?
Rhinitis, Allergic, Perennial
1
2011
20
0.340
Why?
Histamine Antagonists
1
2011
21
0.340
Why?
Rhinitis, Allergic, Seasonal
1
2011
25
0.340
Why?
Quality of Life
9
2026
3187
0.320
Why?
Pulmonary Eosinophilia
2
2022
28
0.310
Why?
Formoterol Fumarate
2
2025
6
0.270
Why?
Treatment Outcome
8
2025
11744
0.260
Why?
Cost of Illness
2
2024
322
0.260
Why?
Practice Guidelines as Topic
3
2024
1581
0.250
Why?
Albuterol
2
2023
76
0.230
Why?
Macrolides
1
2026
68
0.230
Why?
Chronic Disease
4
2024
1824
0.220
Why?
Skin
2
2022
701
0.220
Why?
Allergy and Immunology
1
2024
42
0.200
Why?
Biomarkers
4
2025
4329
0.200
Why?
Geography
1
2024
186
0.200
Why?
Patient Preference
1
2025
224
0.190
Why?
Drug Therapy, Combination
3
2025
1034
0.190
Why?
Budesonide
2
2023
49
0.180
Why?
Adrenergic beta-Agonists
2
2025
91
0.170
Why?
Bayes Theorem
1
2022
424
0.160
Why?
Adult
13
2025
40821
0.160
Why?
Cross-Over Studies
1
2022
612
0.150
Why?
Aged
8
2025
26251
0.140
Why?
Male
13
2025
73014
0.140
Why?
Registries
5
2025
2382
0.140
Why?
Female
14
2025
79080
0.140
Why?
Middle Aged
9
2025
36359
0.140
Why?
Child
7
2025
22638
0.130
Why?
Biofeedback, Psychology
1
2018
35
0.130
Why?
Mastocytosis, Systemic
1
2017
6
0.130
Why?
Dystonia
1
2017
27
0.130
Why?
Movement Disorders
1
2017
68
0.120
Why?
Caregivers
1
2025
1079
0.120
Why?
Omalizumab
1
2016
44
0.120
Why?
Mast Cells
1
2017
148
0.120
Why?
Administration, Oral
2
2025
867
0.120
Why?
Aged, 80 and over
2
2024
8351
0.110
Why?
Anti-Bacterial Agents
1
2026
1935
0.110
Why?
Young Adult
4
2024
14240
0.110
Why?
Randomized Controlled Trials as Topic
3
2026
1754
0.100
Why?
Anti-Inflammatory Agents
1
2018
473
0.100
Why?
Leukocyte Count
2
2025
319
0.100
Why?
Heart Rate
1
2018
844
0.100
Why?
Adolescent
5
2024
22451
0.100
Why?
Combined Modality Therapy
1
2016
1269
0.100
Why?
Comorbidity
3
2024
1652
0.090
Why?
Cardiovascular Diseases
1
2025
2218
0.090
Why?
Disease Management
1
2016
649
0.090
Why?
Receptors, Histamine
1
2011
2
0.090
Why?
History, 19th Century
1
2011
63
0.080
Why?
Administration, Intranasal
1
2011
94
0.080
Why?
Pregnancy
2
2016
7217
0.080
Why?
History, 20th Century
1
2011
330
0.080
Why?
Medication Adherence
1
2014
535
0.080
Why?
Drug Combinations
2
2023
399
0.070
Why?
Cohort Studies
3
2025
6045
0.070
Why?
United States
2
2024
16041
0.070
Why?
Age Factors
1
2016
3321
0.070
Why?
Diagnosis, Differential
1
2012
1500
0.070
Why?
Algorithms
1
2014
1843
0.060
Why?
Delphi Technique
1
2026
347
0.050
Why?
Disease Progression
2
2022
2857
0.050
Why?
Cluster Analysis
1
2025
494
0.050
Why?
Ethanolamines
1
2023
14
0.050
Why?
Antibodies, Anti-Idiotypic
1
2023
50
0.050
Why?
Multimorbidity
1
2023
65
0.050
Why?
Steroids
1
2023
160
0.050
Why?
Age of Onset
1
2024
557
0.040
Why?
Clinical Trials, Phase III as Topic
1
2022
116
0.040
Why?
Proportional Hazards Models
1
2025
1318
0.040
Why?
Seasons
1
2023
535
0.040
Why?
Precision Medicine
1
2025
462
0.040
Why?
Prospective Studies
2
2023
8087
0.040
Why?
Animals
1
2022
38030
0.040
Why?
Databases, Factual
1
2025
1481
0.040
Why?
Immunosuppressive Agents
1
2023
824
0.030
Why?
Carbidopa
1
2017
10
0.030
Why?
Myoclonus
1
2017
16
0.030
Why?
Cell Degranulation
1
2017
40
0.030
Why?
Diphenhydramine
1
2017
36
0.030
Why?
Longitudinal Studies
1
2025
3005
0.030
Why?
Levodopa
1
2017
40
0.030
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2018
344
0.030
Why?
Dopamine
1
2017
295
0.030
Why?
Electroencephalography
1
2018
570
0.030
Why?
Scoliosis
1
2017
230
0.030
Why?
Self Report
1
2018
869
0.030
Why?
Patient Education as Topic
1
2018
769
0.020
Why?
Cross-Sectional Studies
1
2023
5875
0.020
Why?
Inflammation
1
2022
2915
0.020
Why?
Hoyte's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)